Availability of HIV prevention and treatment services for people who inject drugs : findings from 21 countries

Simple item page
dc.contributor.authorPetersen, Zaino
dc.contributor.authorMyers, Bronwyn
dc.contributor.authorVan Hout, Marie-Claire
dc.contributor.authorPluddemann, Andreas
dc.contributor.authorParry, Charles
dc.date.accessioned2013-12-19T10:17:12Z
dc.date.available2013-12-19T10:17:12Z
dc.date.issued2013-08
dc.date.updated2013-12-03T10:41:35Z
dc.descriptionPetersen, Z. et al. 2013. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. Harm Reduction Journal, 10(1):13, doi.org/10.1186/1477-7517-10-13.en
dc.descriptionThe original publication is available at: http://www.harmreductionjournal.com/content/10/1/13en
dc.description.abstractENGLISH ABSTRACT: Background: About a third of the global HIV infections outside sub-Saharan Africa are related to injecting drug use (IDU), and this accounts for a growing proportion of persons living with HIV. This paper is a response to the need to monitor the state of the HIV epidemic as it relates to IDU and the availability of HIV treatment and harm reduction services in 21 high epidemic countries. Methods: A data collection form was designed to cover questions on rates of IDU, prevalence and incidence of HIV and information on HIV treatment and harm reduction services available to people who inject drugs (PWID). National and regional data on HIV infection, IDU in the form of reports and journal articles were sought from key informants in conjunction with a systematic search of the literature. Results: Completed data collection forms were received for 11 countries. Additional country-specific information was sourced via the literature search. The overall proportion of HIV positive PWID in the selected countries ranged from 3% in Kazakhstan to 58% in Vietnam. While IDU is relatively rare in sub-Saharan Africa, it is the main driver of HIV in Mauritius and Kenya, with roughly 47% and 36% of PWID respectively being HIV positive. All countries had antiretroviral treatment (ART) available to PWID, but data on service coverage were mainly missing. By the end of 2010, uptake of needle and syringe programmes (NSP) in Bangladesh, India and Slovakia reached the internationally recommended target of 200 syringes per person, while uptake in Kazakhstan, Vietnam and Tajikistan reached between 100-200 syringes per person. The proportion of PWID receiving opioid substitution therapy (OST) ranged from 0.1% in Kazakhstan to 32.8% in Mauritius, with coverage of less than 3% for most countries. Conclusions: In order to be able to monitor the impact of HIV treatment and harm reduction services for PWID on the epidemic, epidemiological data on IDU and harm reduction service provision to PWID needs to be regularly collected using standardised indicators. Background About a third of the global HIV infections outside sub-Saharan Africa are related to injecting drug use (IDU), and this accounts for a growing proportion of persons living with HIV. This paper is a response to the need to monitor the state of the HIV epidemic as it relates to IDU and the availability of HIV treatment and harm reduction services in 21 high epidemic countries. Methods A data collection form was designed to cover questions on rates of IDU, prevalence and incidence of HIV and information on HIV treatment and harm reduction services available to people who inject drugs (PWID). National and regional data on HIV infection, IDU in the form of reports and journal articles were sought from key informants in conjunction with a systematic search of the literature. Results Completed data collection forms were received for 11 countries. Additional country-specific information was sourced via the literature search. The overall proportion of HIV positive PWID in the selected countries ranged from 3% in Kazakhstan to 58% in Vietnam. While IDU is relatively rare in sub-Saharan Africa, it is the main driver of HIV in Mauritius and Kenya, with roughly 47% and 36% of PWID respectively being HIV positive. All countries had antiretroviral treatment (ART) available to PWID, but data on service coverage were mainly missing. By the end of 2010, uptake of needle and syringe programmes (NSP) in Bangladesh, India and Slovakia reached the internationally recommended target of 200 syringes per person, while uptake in Kazakhstan, Vietnam and Tajikistan reached between 100-200 syringes per person. The proportion of PWID receiving opioid substitution therapy (OST) ranged from 0.1% in Kazakhstan to 32.8% in Mauritius, with coverage of less than 3% for most countries. Conclusions In order to be able to monitor the impact of HIV treatment and harm reduction services for PWID on the epidemic, epidemiological data on IDU and harm reduction service provision to PWID needs to be regularly collected using standardised indicators.en_ZA
dc.description.versionPublishers' Versionen_ZA
dc.format.extent7 p.
dc.identifier.citationPetersen, Z. et al. 2013. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. Harm Reduction Journal, 10(1):13, doi.org/10.1186/1477-7517-10-13.en_ZA
dc.identifier.issn1477-7517 (online)
dc.identifier.otherdoi.org/10.1186/1477-7517-10-13
dc.identifier.urihttp://hdl.handle.net/10019.1/85890
dc.language.isoen_ZAen_ZA
dc.publisherBioMed Centralen_ZA
dc.rights.holderZaino Petersen et al.; licensee BioMed Central Ltd.en_ZA
dc.subjectDrug abusers -- Diseasesen_ZA
dc.subjectHIV infections -- Treatmenten_ZA
dc.subjectHIV positive persons -- Services foren_ZA
dc.titleAvailability of HIV prevention and treatment services for people who inject drugs : findings from 21 countriesen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
1477-7517-10-13.xml
Size:
79.34 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
1477-7517-10-13.pdf
Size:
176.36 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.95 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Psychiatry)